Patients & Public

Videos

MICROB-PREDICT: The project in 3 minutes

In this introductory video, Prof. Dr. Jonel Trebicka, the scientific coordinator of MICROB-PREDICT, provides an overview of the core objectives and focus of the MICROB-PREDICT project.

MICROB-PREDICT: Who are the people behind the science?

22 European institutions join forces in MICROB-PREDICT to improve the prevention and treatment of chronic liver disease (cirrhosis).

MICROB-PREDICT: Interview with ELPA president Marko Korenjak about the EU-funded research project

Former radio moderator (now medical hepatologist) Prof. Dr. Maja Thiele from Odense University Hospital in Denmark interviews Marko Korenjak, the current president of the European Liver Patients’ Association (ELPA) about MICROB-PREDICT, a large 6-year-long EU research project that kicked off in January 2019.

The PREDICT study: Interview of Prof. Dr. Jonel Trebicka by ELPA-President Marko Korenjak

In this interview, Marko Korenjak, president of the European Liver Patients Association (ELPA), inquires about the key results of the large PREDICT study and their meaning for liver disease patients. Prof. Dr. Jonel Trebicka, principal investigator on the PREDICT study and scientific coordinator of MICROB-PREDICT, provides answers and insights.

MICROB-PREDICT: Better microbiome-based stratification of cirrhotic patients (Jonel Trebicka)

In this video, the project’s scientific coordinator, Prof. Dr. Jonel Trebicka, explains why, how, and what MICROB-PREDICT researchers do to reveal the involvement of the human gut microbiome in the complex pathophysiology of late-stage cirrhosis and how the project’s treatment approach may decrease the mortality rate of ACLF patients. The video is a recording of the 2nd presentation given at an online patient event that was jointly organised by ELPA and EF CLIF.

International Liver Congress

Patient representatives from the European Liver Patients’ Association (ELPA) ask Prof. Dr. Jonel Trebicka, the scientific coordinator of MICROB-PREDICT, questions about the project, its clinical studies, and its impact. The interviews were conducted during the International Liver Congress (ILC) in London, United Kingdom.

How do I know when I have acute-on-chronic liver failure (ACLF)?

Patient representative Beatrice Credi from ELPA interviews our coordinator.

How will MICROB-PREDICT change the way I am treated in the hospital?

Patient representative Ivana Dragojević from ELPA interviews our coordinator.

How often and where will albumin be administered to cirrhosis patients? 

Patient representative Marinela Debu from ELPA interviews our coordinator.